Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Caon

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Journal of the Neurological Sciences|February 10, 2009
Maximising therapeutic outcomes in patients failing on current therapyChristina Caon
The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses|November 6, 2010
Factors that influence adherence and strategies to maintain adherence to injected therapies for patients with multiple sclerosisCarol Saunders, Christina Caon, Jennifer Smrtka, et al.
International Journal of MS Care|January 24, 2014
Efficacy and safety of alemtuzumab in multiple sclerosis and impact on nursing roleChristina Caon, Cathy Meyer, Lori Mayer, et al.
The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses|November 6, 2010
Injectable disease-modifying therapy for relapsing-remitting multiple sclerosis: a review of adherence dataChristina Caon, Carol Saunders, Jennifer Smrtka, et al.
The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses|November 6, 2010
Enhancing adherence through educationJennifer Smrtka, Christina Caon, Carol Saunders, et al.
Expert Review of Neurotherapeutics|October 9, 2009
Glatiramer acetate for multiple sclerosis: a comprehensive review of mechanisms and clinical efficacyMarina Zvartau-Hind, Christina Caon, Rana Zabad, et al.
CNS Drugs|July 5, 2002
Comparative assessment of immunomodulating therapies for relapsing-remitting multiple sclerosisOmar Khan, Rana Zabad, Christina Caon, et al.
Journal of Managed Care Pharmacy : JMCP|February 7, 2013
Narrative review of the literature on adherence to disease-modifying therapies among patients with multiple sclerosisJoseph Menzin, Christina Caon, Christine Nichols, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|February 29, 2008
Long-term study of brain 1H-MRS study in multiple sclerosis: effect of glatiramer acetate therapy on axonal metabolic function and feasibility of long-Term H-MRS monitoring in multiple sclerosisOmar Khan, Yimin Shen, Fen Bao, et al.
Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society|August 22, 2015
Best Practices in Alemtuzumab Administration: Practical Recommendations for Infusion in Patients With Multiple SclerosisLynn McEwan, Christina Caon, Carol Chieffe, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Journal of the Neurological Sciences|February 10, 2009
Maximising therapeutic outcomes in patients failing on current therapyChristina Caon
The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses|November 6, 2010
Factors that influence adherence and strategies to maintain adherence to injected therapies for patients with multiple sclerosisCarol Saunders, Christina Caon, Jennifer Smrtka, et al.
International Journal of MS Care|January 24, 2014
Efficacy and safety of alemtuzumab in multiple sclerosis and impact on nursing roleChristina Caon, Cathy Meyer, Lori Mayer, et al.
The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses|November 6, 2010
Injectable disease-modifying therapy for relapsing-remitting multiple sclerosis: a review of adherence dataChristina Caon, Carol Saunders, Jennifer Smrtka, et al.
The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses|November 6, 2010
Enhancing adherence through educationJennifer Smrtka, Christina Caon, Carol Saunders, et al.
Expert Review of Neurotherapeutics|October 9, 2009
Glatiramer acetate for multiple sclerosis: a comprehensive review of mechanisms and clinical efficacyMarina Zvartau-Hind, Christina Caon, Rana Zabad, et al.
CNS Drugs|July 5, 2002
Comparative assessment of immunomodulating therapies for relapsing-remitting multiple sclerosisOmar Khan, Rana Zabad, Christina Caon, et al.
Journal of Managed Care Pharmacy : JMCP|February 7, 2013
Narrative review of the literature on adherence to disease-modifying therapies among patients with multiple sclerosisJoseph Menzin, Christina Caon, Christine Nichols, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|February 29, 2008
Long-term study of brain 1H-MRS study in multiple sclerosis: effect of glatiramer acetate therapy on axonal metabolic function and feasibility of long-Term H-MRS monitoring in multiple sclerosisOmar Khan, Yimin Shen, Fen Bao, et al.
Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society|August 22, 2015
Best Practices in Alemtuzumab Administration: Practical Recommendations for Infusion in Patients With Multiple SclerosisLynn McEwan, Christina Caon, Carol Chieffe, et al.
Pageof 3